Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
J.Jill	JILL	8. jan 2025	27.10	-0.66
Jabil	JBL	8. jan 2025	153.95	+0.80
Jack Henry & Associates	JKHY	8. jan 2025	173.45	+1.23
Jack In The Box	JACK	8. jan 2025	38.13	-2.16
Jackson Financial	JXN-A	8. jan 2025	26.35	-0.53
Jackson Financial	JXN	8. jan 2025	88.61	-1.39
Jacobs Engineering Group	J	8. jan 2025	133.10	+0.95
Jaguar Health	JAGX	8. jan 2025	1.09	-7.63
JAKKS Pacific	JAKK	8. jan 2025	28.44	-0.94
James Hardie Industries ADR	JHX	8. jan 2025	31.12	+0.71
James River Group Holdings	JRVR	8. jan 2025	4.66	-2.10
Jamf	JAMF	8. jan 2025	14.13	-0.28
Janover	JNVR	8. jan 2025	5.50	-1.93
Janus Henderson Group	JHG	8. jan 2025	42.41	+0.93
Janus International Group	JBI	8. jan 2025	7.00	-5.02
Janus Small Cap Growth Alpha ETF	JSML	8. jan 2025	65.59	+0.38
Janus Small/Mid Cap Growth Alpha ETF	JSMD	8. jan 2025	75.88	+0.53
Janux Therapeutics	JANX	8. jan 2025	50.82	-12.09
Japan Alphadex First Trust	FJP	8. jan 2025	51.55	+0.19
Japan Hedged Equity Wisdomtree	DXJ	8. jan 2025	110.69	-0.05
Japan Index MSCI Ishares	EWJ	8. jan 2025	67.10	-0.25
Japan Smallcap Dividend Wisdomtree	DFJ	8. jan 2025	73.74	-0.79
Japan Smallcap Index MSCI Ishares	SCJ	8. jan 2025	72.36	-0.47
Japan Smaller Capitalization Fund	JOF	8. jan 2025	7.61	-1.30
Japanese Yen Trust	FXY	8. jan 2025	58.31	-0.31
Jasper Therapeutics A	JSPR	8. jan 2025	6.99	-60.53
Jayud Global Logistics	JYD	8. jan 2025	2.03	-12.88
Jazz Pharmaceuticals	JAZZ	8. jan 2025	120.23	-1.89
JBDI Holdings Limited - Ordinary Shares	JBDI	8. jan 2025	0.85	+20.03
JBG Smith Properties	JBGS	8. jan 2025	14.94	-0.86

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.